BMO Capital Markets lowered their price target on Paycor HCM from $24.00 to $23.00 and set a “market perform” rating for the company in a report on Thursday, November 9th.

Source: https://www.americanbankingnews.com/2023/12/03/paycor-hcm-inc-nasdaqpycr-shares-sold-by-us-bancorp-de.html

Citigroup lowered their target price on Ceridian HCM from $73.00 to $68.00 in a report on Friday, October 21st.

Source: https://www.americanbankingnews.com/2023/01/20/ceridian-hcm-holding-inc-nysecday-stock-holdings-increased-by-ellevest-inc.html

Cook County medical examiner’s office records showed that the 19-year-old died of hypertrophic cardiomyopathy, or HCM.

Source: https://www.bostonherald.com/2023/01/03/how-common-is-cardiac-arrest-in-young-athletes-local-experts-weigh-in-after-damar-hamlins-collapse/

Cowen lifted their target price on Ceridian HCM from $77.00 to $87.00 and gave the stock an “outperform” rating in a report on Thursday, February 9th.

Source: https://www.etfdailynews.com/2023/05/15/nordea-investment-management-ab-lowers-holdings-in-ceridian-hcm-holding-inc-nysecday/

Credit Suisse Group lifted their price objective on Ceridian HCM from $90.00 to $105.00 and gave the company an “outperform” rating in a research report on Thursday, February 9th.

Source: https://www.americanbankingnews.com/2023/03/01/ceridian-hcm-holding-inc-nysecday-cfo-noemie-clemence-heuland-sells-3211-shares-of-stock.html

DA Davidson dropped their price target on shares of Ceridian HCM from $86.00 to $77.00 in a research note on Thursday, May 4th.

Source: https://www.etfdailynews.com/2023/07/13/ceridian-hcm-holding-inc-nysecday-shares-purchased-by-fifth-third-bancorp/

DA Davidson reduced their target price on shares of Ceridian HCM from $86.00 to $77.00 in a research report on Thursday, May 4th.

Source: https://www.etfdailynews.com/2023/07/15/asset-management-one-co-ltd-has-4-37-million-holdings-in-ceridian-hcm-holding-inc-nysecday/

Freedom Wealth Alliance LLC purchased a new position in shares of Ceridian HCM during the 4th quarter worth $49,000.

Source: https://www.americanbankingnews.com/2023/08/19/hartford-investment-management-co-grows-position-in-ceridian-hcm-holding-inc-nysecday.html

In addition, WDAY is expanding its portfolio beyond core HCM solutions into the financial domain and is customizing them for diverse industries and verticals.

Source: https://247wallst.com/investing/2023/08/28/5-nasdaq-stocks-to-buy-as-index-returned-to-green-last-week/

In other Paycor HCM news, insider Alice L. Geene sold 1,267 shares of Paycor HCM stock in a transaction that occurred on Tuesday, April 25th.

Source: https://www.etfdailynews.com/2023/05/08/34800-shares-in-paycor-hcm-inc-nasdaqpycr-bought-by-mitsubishi-ufj-kokusai-asset-management-co-ltd/

In other Paycor HCM news, insider Alice L. Geene sold 1,267 shares of Paycor HCM stock in a transaction that occurred on Tuesday, April 25th.

Source: https://www.etfdailynews.com/2023/05/08/34800-shares-in-paycor-hcm-inc-nasdaqpycr-bought-by-mitsubishi-ufj-kokusai-asset-management-co-ltd/

In summary, we are as optimistic about our opportunity in HCM as we've ever been.

Source: https://seekingalpha.com/article/4629118-paycor-hcm-inc-pycr-q2-2023-earnings-call-transcript?source=feed_all_articles

Key anchor systems that support the enterprise—core platforms like customer relationship management (CRM), human capital management (HCM), financial management, inventory management, and more—can help reduce security risk and data silos.

Source: https://fortune.com/2023/08/10/workday-data-ai-revolution/

Lazard Asset Management LLC bought a new stake in Ceridian HCM in the third quarter valued at about $25,000.

Source: https://www.etfdailynews.com/2023/06/01/dimensional-fund-advisors-lp-purchases-30423-shares-of-ceridian-hcm-holding-inc-nysecday/

Moffett Nathanson assumed coverage on Ceridian HCM in a report on Monday, January 9th.

Source: https://www.etfdailynews.com/2023/04/23/dekabank-deutsche-girozentrale-raises-stock-position-in-ceridian-hcm-holding-inc-nysecday/

Robert W. Baird lifted their target price on Ceridian HCM from $78.00 to $86.00 and gave the company an “outperform” rating in a report on Friday, February 10th.

Source: https://www.etfdailynews.com/2023/02/22/bank-of-montreal-can-grows-stock-holdings-in-ceridian-hcm-holding-inc-nysecday/

TD Cowen downgraded Ceridian HCM from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $69.00 to $71.00 in a research note on Thursday, July 13th.

Source: https://www.dailypolitical.com/2023/10/29/illinois-municipal-retirement-fund-makes-new-investment-in-ceridian-hcm-holding-inc-nysecday.html

The study involved approximately 300 individuals with HCM, and those who received Cytokinetics drug, Alicante, experienced significant improvements in their peak oxygen uptake after 24 weeks of treatment.

Source: https://www.chiangraitimes.com/health/aficamten-a-heart-drug-by-cytokinetics/